Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

Assignee

• Mediquest Therapeutics
• University Of Kansas

Inventors

• Mark R. Burns (21 patents)
• Sunil A. David (18 patents)

View full patent text on Google Patents →